Common use of Purchase Money Debt Clause in Contracts

Purchase Money Debt. Maximum $1,000,000 per fiscal year Actual cumulative purchase money debt for subject fiscal year equals $_____________ Yes No A. The undersigned has individually reviewed the provisions of the Credit Agreement and a review of the activities of Borrower during the period covered by this Compliance Certificate has been made in reasonable detail by or under the supervision of the undersigned with a view to determining whether Borrower has kept, observed, performed and fulfilled all of its obligations under the Credit Agreement. B. Such review did not disclose, and I have no knowledge of, the existence of any Default or Event of Default which has occurred and is continuing [except as disclosed on the attachment hereto]. Executed this ______ day of __________________, 20___. THERAGENICS CORPORATION By: THIS CREDIT AGREEMENT JOINDER AGREEMENT (this “Agreement”) is made as of __________________, 20_____, among Theragenics Corporation, a Delaware corporation, C.P. Medical Corporation, a Delaware corporation, Galt Medical Corp., a Texas corporation [and] NeedleTech Products, Inc., a Massachusetts corporation [and list and previous Additional Borrowers] (collectively, the “Existing Borrowers”) and ________________________________, a _______________________________ (the “Additional Borrower”) and Wachovia Bank, National Association, successor by merger to SouthTrust Bank (the “Bank”);

Purchase Money Debt. Maximum $1,000,000 per fiscal year Actual cumulative purchase money debt for subject fiscal year equals $_____________ Yes No A. The undersigned has individually reviewed the provisions of the Credit Agreement and a review of the activities of Borrower during the period covered by this Compliance Certificate has been made in reasonable detail by or under the supervision of the undersigned with a view to determining whether Borrower has kept, observed, performed and fulfilled all of its obligations under the Credit Agreement. B. Such review did not disclose, and I have no knowledge of, the existence of any Default or Event of Default which has occurred and is continuing [except as disclosed on the attachment hereto]. Executed this ______ day of __________________, 20___. THERAGENICS CORPORATION By: THIS SECOND AMENDMENT TO AMENDED AND RESTATED CREDIT AGREEMENT JOINDER AGREEMENT (this “Agreement”"Amendment") is made dated as of __________________February 17, 20_____2012, among Theragenics Corporation, a Delaware corporation(i) THERAGENICS CORPORATION, C.P. Medical CorporationMEDICAL CORPORATION, GALT MEDICAL CORP. and NEEDLETECH PRODUCTS, INC. (each a Delaware corporation"Borrower" and collectively the "Borrowers"), Galt Medical Corp.and (ii) XXXXX FARGO BANK, a Texas corporation [and] NeedleTech ProductsNATIONAL ASSOCIATION, Inc., a Massachusetts corporation [and list and previous Additional Borrowers] (collectively, the “Existing Borrowers”) and ________________________________, a _______________________________ (the “Additional Borrower”) and successor in interest by merger to Wachovia Bank, National Association, successor by merger to SouthTrust Bank Association (the “"Bank”");

Purchase Money Debt. Maximum $1,000,000 per fiscal year Actual cumulative purchase money debt for subject fiscal year equals $_____________ Yes No A. The undersigned has individually reviewed the provisions of the Credit Agreement and a review of the activities of Borrower during the period covered by this Compliance Certificate has been made in reasonable detail by or under the supervision of the undersigned with a view to determining whether Borrower has kept, observed, performed and fulfilled all of its obligations under the Credit Agreement. B. Such review did not disclose, and I have no knowledge Knowledge of, the existence of any Default or Event of Default which has occurred and is continuing [except as disclosed on the attachment hereto]. Executed this ______ day of __________________, 20___. THERAGENICS CORPORATION By: THIS CREDIT AGREEMENT JOINDER AGREEMENT (this “Agreement”) is made as of __________________, 20_____, among Theragenics Corporation, a Delaware corporation, C.P. Medical Corporation, a Delaware corporation, Galt Medical Corp., a Texas corporation [and] NeedleTech Products, Inc., a Massachusetts corporation [and list and any previous Additional Borrowers] (collectively, the “Existing Borrowers”) and ________________________________, a _______________________________ (the “Additional Borrower”) and Wachovia Xxxxx Fargo Bank, National Association, successor by merger to SouthTrust Bank Wachovia Bank, National Association (the “Bank”);